Healthy Skepticism Library item: 582
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Wolfe S.
Drug advertisements that go straight to the hippocampus.
Lancet 1996 Sep 7; 348:(9028):632
Keywords:
*analysis
quality of prescribing
source of information
doctors
regulation of promotion
Food and Drug Administration
FDA
journal advertisements
ETHICAL ISSUES IN PROMOTION: GIFT GIVING
ETHICAL ISSUES IN PROMOTION: PAYMENT FOR MEALS, ACCOMODATION, TRAVEL, ENTERTAINMENT
EVALUATION OF PROMOTION: JOURNAL ADVERTISEMENTS
INFLUENCE OF PROMOTION: PRESCRIBING, DRUG USE
PROMOTION DISGUISED: CLINICAL TRIALS
PROMOTION DISGUISED: CONFERENCES AND MEETINGS
PROMOTION DISGUISED: GHOST-WRITING AND JOURNAL ARTICLES
PROMOTION DISGUISED: SUPPORT FOR CME
REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS
REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION
REGULATION, CODES, GUIDELINES: HEALTH PROFESSIONAL ORGANIZATIONS
REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION
Notes:
Advertisements are now appearing in marketing oriented journals from companies selling marketing services that promise to produce communications that “are focused on making the hippocampus . . . the prescription-writing center of the [doctor’s] brain . . . respond positively to your product.†Perhaps this process accounts for the poor prescribing of many physicians which is linked to drug industry spending on promotion. Physicians should support efforts by relevant agencies to police drug advertising. There is potential lack of compliance with Food and Drug Administration regulations on drug advertising 92% of advertisements.
